The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies

Publication | Closed Access

DOI

127

Citations

References

1999

Year

Benjamin Movsas, Charles Scott, William T. Sause, Roger W. Byhardt, Ritsuko Komaki, James Cox, Douglas H. Johnson, C.A. Lawton, A. Rashid Dar, Todd H. Wasserman,

International Journal of Radiation Oncology*Biology*Physics

Adaptive RadiotherapyRadiation MedicineRadiation TherapyMedicineTreatment IntensificationChemoradiation StudiesQuality-adjusted Survival AnalysisClinical Radiation OncologyOncologyRadiation OncologyLung Cancer